Идёт
Фаза III
Армения
Ivosidenib Oral Tablet · Servier Affaires Médicales
An Open-Label Early Access Phase 3b Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma